Open AccessMaintenance Treatment Post-transplant
Author(s) -
Fernando Barroso Duarte,
Eduardo Paton
Publication year - 2021
Publication title -
journal of bone marrow transplantation and cellular therapy
Language(s) - English
Resource type - Journals
ISSN - 2675-374X
DOI - 10.46765/2675-374x.2021v2n2p89
Subject(s) - medicine , disease , transplantation , oncology , minimal residual disease , intensive care medicine , leukemia
Disease recurrence is the most common cause of HCT failure in patients with AML,ALL and SMD and factors such as the presence of measurable residual disease before and after transplantation, stage of the disease before transplantation and the cytogenetic and molecular risk profile are factors associated with increased risk of recurrence.